S ome parasites are innocuous or even beneficial to mammalian hosts. The gastrointestinal helminths modulate several important intestinal functions such as immunomodulation. In contrast, infections by pathogenic parasites are the cause of numerous epidemics and serious diseases. The inflammatory response to infection must be tightly regulated in order to achieve pathogen clearance whilst avoiding consequences of deregulated gene expression.
The discovery of small non-coding RNAs called microRNAs (miRNAs) in eukaryotic cells has greatly expanded our understanding around the mechanisms of regulation of gene expression. 1 Recently, the miRNAs biosynthesis and mechanism of action have well been documented. Regarding their mechanism of action, miRNAs most often silence gene expression following association with mRNA targets and Argonaute proteins (Ago), thereby forming the miRNA-induced silencing complex (miRISC). Numerous miRNAs can also be identified in extracellular compartments; for example, when associated with Ago in plasma, when contained within exosomes, or when small membrane vesicles bud off the cell surface into the extracellular space. These biofluid miRNAs have increasingly been validated as robust biomarkers for disease and organ damage. Regarding their wide and intricate regulatory roles and their ubiquity, as well as their sequence specificity, miRNAs arise as potential alternative diagnostic and therapeutic targets for parasitic diseases. The sequences of parasitic miRNAs could provide a new plan to investigate gene regulation, development and evolutionary processes in parasites, while decisively help to decipher hostparasite interactions and relationships.
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